Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Carcinoma, Anaplastic × Pemetrexed × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 167 Lung Neoplasms 61 Neoplasms 21 Neoplasm Metastasis 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Mesothelioma, Malignant 12 Colorectal Neoplasms 10 Carcinoma 10 Meningeal Carcinomatosis 9 Mesothelioma 6 Melanoma 6 Brain Neoplasms 6 NSCLC 5 Adenocarcinoma of Lung 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Neoplasms by Site 4 Lung Diseases 4 Carcinoma, Bronchogenic 4 Advanced Solid Tumors 4 Thoracic Neoplasms 3 Small Cell Lung Carcinoma 3 Respiratory Tract Neoplasms 3 Rectal Neoplasms 3 Neoplasms by Histologic Type 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Bronchial Neoplasms 3

Interventions

trametinib 5 dabrafenib 5 pembrolizumab 2 cobimetinib 2 atezolizumab 2 Vemurafenib 2 Radiotherapy, Intensity-Modulated 2 Paclitaxel 2 zimberelimab 1 tislelizumab 1 surufatinib 1 selpercatinib 1 lenvatinib 1 fludarabine 1 cemiplimab 1 cabozantinib 1 aldesleukin 1 abemaciclib 1 Taxes 1 Nivolumab 1 Ipilimumab 1 Immunoglobulin G 1 Disulfides 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡